TITania Islam

Tania Islam

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Tania Islam has a total of 147 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Neutrophil gelatinase-associated lipocalin in contrast-induced acute kidney injury post cardiac procedure: a systematic review

    by Sabah Mohammed Al-Harazi, Meram Azzani, Lubna Shirin, Mohammed Shahjahan Kabir, Thekra Haza'A Abdulhameed, Deepa Anbazhagan, Tania Islam

  • Open Access

    Longitudinal association of physical activity with quality of life domains among malaysian breast cancer survivors

    by Yi Lin Lee, Tania Islam, Mahmoud Danaee, Nur Aishah Taib, MyBCC study group

    The widely documented benefits of physical activity (PA) for breast cancer (BC) survivors include reductions in morbidity and mortality and enhanced quality of life (QOL). This study examined QOL changes over time and the association between PA and QOL. A prospective cohort study followed 133 BC survivors at baseline, one year and three years after diagnosis. PA was measured using the Global Physical Activity Questionnaire (GPAQ), and QOL was assessed using the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaires. PA levels were classified as active (≥ 600 MET-min/week) or inactive (< 600 MET-min/week) per WHO recommendations. Generalised Estimating Equations (GEE) were used to analyse the associations between PA and QOL domains over time. The study followed 133 women (mean age of 56.9 years) at baseline, one year, and three years. PA levels declined over time, with active survivors dropping from 48.1% at baseline to 35.3% at three years. Overall, QOL declined over time. Global health status decreased from 77.8 (SD = 12.9) at baseline to 71.1 (SD = 17.0) at three years (p < 0.001). Physical functioning dropped from 95.1 (SD = 11.5) to 88.7 (SD = 13.4) (p < 0.001), and cognitive functioning from 87.3 (SD = 15.6) to 80.6 (SD = 18.8) (p = 0.001). Fatigue increased from 11.8 (SD = 15.1) at baseline to 17.2 (SD = 16.2) at three years (p = 0.006). Insomnia was the most severe symptom with the highest mean score of 18.55 among all the symptom scales. From baseline to 3 years, systemic therapy side effects increased from 6.30 to 10.06 (p = 0.001); arm symptoms from 8.60 to 14.62 (p = 0.010). Higher PA levels were associated with improved role functioning. Additionally, PA at one year improved constipation symptoms. This study highlights significant declines in PA and QOL among Malaysian BC survivors, with PA showing a protective effect on specific QOL domains. Future research is needed to develop effective interventions to promote long-term PA maintenance.

  • Open Access

    Impact of Mitochondrial Dysfunction on Hormone-Responsive Breast Cancer Metastasis

    by Mohammed Shahjahan Kabir, Lubna Shirin, Priyanka Chadha, Sergey Gupalo, Jegathambigai, Nirmala P, Ramesh Thevendran, Rohini Karunakaran, Maheswaran Solayappan, Aye Aye Tun, et al.

    Mitochondrial liability is emerging as a central mechanism amplifying the metastasis of hormone-responsive breast cancer, yet the precise roles whereby steroid hormone signaling modifies mtDNA and organelle function are ill-defined. We employed ER+/PR+ highlights (MCF-7, T47D) and pulsatile estradiol and progesterone exposure, quantifying mitochondrial metrics via the Seahorse XF platform (OCR/ECAR), high-resolution confocal 3D reconstruction, and COMSOL Multiphysics finite element modeling for ROS extraction. Hormonal stimulation triggered a distinct bioenergetic reprogramming, manifesting as a 1.8-fold escalation in basal O2 consumption and a 2.1-fold enhancement in glycolytic capacity compared to vehicle (p<0.001). Structural assays identified a 36% contraction of polar mitochondrial branches and increased fission, coinciding with a ROS surge reaching 150% of pluripotent basal levels focalized to the perinuclear mitochondrial cloud. Monte Carlo-derived metastatic timelines predicted that merged bioenergetic and fission metrics elevated the simulated xenograft hazard ratio by 42% over 18 months. Extensive interrogation of hormone-independent datasets confirmed this mitochondrial, structural, and ROS axis is distinctively reprogrammed in metastatic, hormone-dependent disease. Collectively, these integrated multi-scale data authenticate a hormone-dependent mitochondrial reprogramming axis that drives metastatic outgrowth, advocating for mt-targeting strategies in ER+/PR+ breast therapeutics

  • Open Access

    Breast conserving surgery versus mastectomy: the effect of surgery on quality of life in breast cancer survivors in Malaysia

    by Maznah Dahlui, Meram Azzani, Nur Aishah Taib, See Mee Hoong, Suniza Jamaris, Tania Islam

    Background: In the competitive health care environment, patient satisfaction and quality of life (QoL) have become the subject of interest to evaluate the efficacy of therapeutic interventions as we experience improved breast cancer survival in modern times. The knowledge of the long-term effects of surgery on the QoL in breast cancer patients is currently limited in the Asian setting. The purpose of this longitudinal study is to evaluate the QoL of early-stage breast cancer patients undergoing mastectomy and breast-conserving surgery (BCS). Methods: In this prospective cohort study, the QoL of 208 patients who underwent mastectomy and the BCS treatment were assessed, using the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire. The questionnaire was administered at the baseline, 6 and 12 months following diagnosis. One-way ANCOVA was used for statistical analysis. Results: A total of 208 female survivors of Stage 0–II breast cancer were included, among them 47.1% underwent BCS and 52.9% underwent mastectomy. Older (63.3%), Chinese women (63.6%), and patients with primary education (71.7%) were more likely to undergo mastectomy. At baseline, no significant differences were observed for QoL in both treatment groups. At 6 months, patients who underwent BCS had better social functioning scales( P = 0.006) and worse symptom scales for dyspnoea (P = 0.031), compared to mastectomy patients. One year after diagnosis, the role functioning score of the mastectomy group was significantly higher than the BCS group, specifically among patients who had undergone chemotherapy (P = 0.034). Conclusion: Patients who underwent BCS had better social functioning and worse dyspnoea symptoms compared to patients undergoing mastectomy at six months. During one year, there were only significant improvements in the role functioning among the mastectomy groups compared to the BCS groups. After further stratification, only mastectomy patients who received chemotherapy exhibited improved role functioning compared to patients those who did not undergo chemotherapy. Providing social and physical support postoperatively and monitoring patients for cancer worry, or other symptoms in the long-term survivorship period would be important to ensure optimal QoL.


  • Open Access

    Chest Computed Tomography (CT) and Clinical Findings Among COVID-19 Patients of Tertiary Hospital in Bangladesh

    by Tarek Shams, Jamil Haider Chowdhury, Hasna Hena Chowdhury, Qumrul Ahsan, Hrionmoy Dutta, Mohammad Ali Tareq, Lubna Shirin, Sanjida Akhter, Tania Islam

    Pertanika Journal information and guidelines

  • Open Access

    Physical Activity and Quality of Life in Malaysian Breast Cancer Survivors: A Longitudinal Study

    by Tania Islam, Lee Yi Lin, Mahmoud Danaee, Nur Aishah Taib

    PURPOSE: Regular physical activity (PA) after a diagnosis of breast cancer(BC) is associated with reduced morbidity and a higher quality of life (QOL). Investigate the association of PA and QOL among Malaysian BC survivors in this prospective cohort study. METHODS: A total of, 133 BC women were interviewed at baseline, one year, and three-year after diagnosis of BC in a tertiary referral center in Klang Valley. The Global Physical Activity Questionnaire and the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire were used to measure PA and QOL of the survivors. A generalized estimating equation was performed to examine the association of PA and QOL longitudinally. RESULTS: The mean age was 56.89 (± 10.56) years old, and the majority were Chinese (50.4%). At baseline, 48.1% of patients were active and it declined to 39.8% at one year, and 35.3% at third year. Three years after diagnosis (Adjusted Odds Ratio [AOR]: 1.74, P = .021), being underweight (AOR: 3.43, P = .004) and being Malay (AOR: 1.86, P = .042) were found to be significant associating factors with inactivity. Overall, the QOL was observed to decrease over the years. Global health status, physical and cognitive functioning had a significant declining trend from baseline to three years ( P = < 0.001, P = < 0.001 and P = .001 respectively). For symptom scales, patients experienced more fatigue over time too ( P = .006). When analysing the association of PA and QOL, being active significantly improve role functioning ( P = .022). At one year, being active also significantly reduced constipation symptoms ( P = .048). CONCLUSION: The findings showed that BC survivors in Malaysia had inadequate PA levels at diagnosis and further decreased over time. Their QOL had a declining trend, but PA was found to improve constipation symptoms and role functioning. Thus, it is essential to promote PA throughout their follow-ups with more focus on Malay ethnicity.


  • Open Access

    Overlap of high-risk individuals predicted by family history, and genetic and non-genetic breast cancer risk prediction models: implications for risk stratification

    by Peh Joo Ho, Weang Kee Ho, Alexis J. Khng, Yen Shing Yeoh, Benita Kiat-Tee Tan, Ern Yu Tan, Geok Hoon Lim, Su-Ming Tan, Veronique Kiak Mien Tan, Cheng-Har Yip, et al.

    Background: Family history, and genetic and non-genetic risk factors can stratify women according to their individual risk of developing breast cancer. The extent of overlap between these risk predictors is not clear. Methods: In this case-only analysis involving 7600 Asian breast cancer patients diagnosed between age 30 and 75 years, we examined identification of high-risk patients based on positive family history, the Gail model 5-year absolute risk [5yAR] above 1.3%, breast cancer predisposition genes (protein-truncating variants [PTV] in ATM, BRCA1, BRCA2, CHEK2, PALB2, BARD1, RAD51C, RAD51D, or TP53), and polygenic risk score (PRS) 5yAR above 1.3%. Results: Correlation between 5yAR (at age of diagnosis) predicted by PRS and the Gail model was low (r=0.27). Fifty-three percent of breast cancer patients (n=4041) were considered high risk by one or more classification criteria. Positive family history, PTV carriership, PRS, or the Gail model identified 1247 (16%), 385 (5%), 2774 (36%), and 1592 (21%) patients who were considered at high risk, respectively. In a subset of 3227 women aged below 50 years, the four models studied identified 470 (15%), 213 (7%), 769 (24%), and 325 (10%) unique patients who were considered at high risk, respectively. For younger women, PRS and PTVs together identified 745 (59% of 1276) high-risk individuals who were not identified by the Gail model or family history. Conclusions: Family history and genetic and non-genetic risk stratification tools have the potential to complement one another to identify women at high risk.


  • Open Access

    An Artificial Intelligence-Enabled Pipeline for Medical Domain: Malaysian Breast Cancer Survivorship Cohort as a Case Study

    by Mogana Darshini Ganggayah, Sarinder Kaur Dhillon, Tania Islam, Foad Kalhor, Teh Chean Chiang, Elham Yousef Kalafi, Nur Aishah Taib

    Automated artificial intelligence (AI) systems enable the integration of different types of data from various sources for clinical decision-making. The aim of this study is to propose a pipeline to develop a fully automated clinician-friendly AI-enabled database platform for breast cancer survival prediction. A case study of breast cancer survival cohort from the University Malaya Medical Centre was used to develop and evaluate the pipeline. A relational database and a fully automated system were developed by integrating the database with analytical modules (machine learning, automated scoring for quality of life, and interactive visualization). The developed pipeline, iSurvive has helped in enhancing data management as well as to visualize important prognostic variables and survival rates. The embedded automated scoring module demonstrated quality of life of patients whereas the interactive visualizations could be used by clinicians to facilitate communication with patients. The pipeline proposed in this study is a one-stop center to manage data, to automate analytics using machine learning, to automate scoring and to produce explainable interactive visuals to enhance clinician-patient communication along the survivorship period to modify behaviours that relate to prognosis. The pipeline proposed can be modelled on any disease not limited to breast cancer.


  • Adherence rate and the factors contribute toward the surgical adherence of breast cancer in Malaysia

    by Mao Li Cheng, Mee Hoong See, Siamala Sinnadurai, Tania Islam, Adlinda Alip, Chong Guan Ng, Nur Aishah Taib, the MyBCC Study Group

    Click on the article title to read more.